(Q34562942)

3 August 2017

1 reference

title

Chapter 6: Epidemiology and transmission dynamics of genital HPV infection (English)

1 reference

3 August 2017

1 reference

3

Silvia de Sanjosé

0 references

Eduardo L. Franco

object named as

Eduardo L Franco

series ordinal

4

0 references

Ann N Burchell

series ordinal

1

object named as

Ann N Burchell

1 reference

3 August 2017

2

Rachel L Winer

1 reference

PubMed ID

16950018

3 August 2017

language of work or name

English

0 references

publication date

2 June 2006

1 reference

3 August 2017

1 reference

3 August 2017

24 Suppl 3

1 reference

3 August 2017

S3/52-61

1 reference

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

The epidemiology of genital human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Genital human papillomavirus infection in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Seroprevalence of human papillomavirus type 16 infection in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Measuring sexual behaviour in the era of HIV/AIDS: the experience of Demographic and Health Surveys and similar enquiries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Gap length: an important factor in sexually transmitted disease transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Human papillomavirus infection and use of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Detection of high-risk human papillomavirus in the cervix and semen of sex partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Prevalence and determinants of human papillomavirus genital infection in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Genital human papillomavirus infection in women who have sex with women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Detection of human papillomavirus DNA on the fingers of patients with genital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Seroprevalence of human papillomavirus type 16 in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

Condom use and the risk of genital human papillomavirus infection in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.031

10.1016/J.VACCINE.2006.05.031

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

16950018